Core Attributes
|
Attribute |
Value |
Source |
|
INCI Name |
Resveratrol |
|
|
Chemical Name |
3,4',5-trihydroxystilbene |
|
|
CAS Number |
501-36-0 |
Standard database |
|
Molecular Formula |
C₁₄H₁₂O₃ |
Standard database |
|
Molecular Weight |
228.25 g/mol |
Standard database |
|
Active Form |
Trans-resveratrol |
|
|
Compound Classification |
Polyphenol, phytoestrogen, phytoalexin |
|
|
Bioactive Derivatives |
Resveratrol isobutyrate, resveratrol butyrate, resveratryl triglycolate |
|
|
Most Effective Forms |
Isobutyrate and butyrate derivatives |
|
Clinical Efficacy Attributes
12-Week Topical Study
|
Parameter |
Result |
Source |
|
Fine lines |
Significant improvement |
|
|
Wrinkles |
Significant reduction |
|
|
Skin elasticity |
Significantly improved |
|
45-Day Study (24 volunteers)
|
Parameter |
Responders |
Source |
|
Pore size reduction (forehead) |
19 of 24 subjects |
|
|
Pore size reduction (buccal area) |
14 of 24 subjects |
|
|
Pigmentation decrease (forehead) |
7 of 24 subjects |
|
|
Pigmentation decrease (buccal area) |
4 of 24 subjects |
|
60-Day Oral Supplementation
|
Parameter |
Result |
Source |
|
Skin hydration |
Improved |
|
|
Skin texture |
Smoother |
|
|
Eczema/psoriasis |
Condition improved |
|
UV-Irradiated Fibroblast Studies
|
Biomarker |
Effect vs Control |
Source |
|
Procollagen 1 |
Higher content after UV exposure |
|
|
Matrix metalloproteinase 1 |
Lower activity |
|
|
Elastin |
Prevented UV-induced decrease |
|
Mechanism Attributes
Gene Induction
|
Gene/Protein |
Effect |
Source |
|
Collagen type A1 |
Increased synthesis |
|
|
TIMP-1 (Tissue inhibitor of MMPs) |
Increased expression |
|
|
Fibrillin 1 |
Increased (derivatives only; pure resveratrol neutral) |
|
|
AMPK |
Activated |
|
|
Autophagocytes |
Stimulated production |
|
|
LC3-II |
Increased (autophagy marker) |
|
Gene/Pathway Inhibition
|
Target |
Effect |
Source |
|
Survivin |
Blocks protein and mRNA |
|
|
Cyclin-dependent kinase 2, 4, 6 |
Inhibited |
|
|
Nuclear factor κB |
Blocked |
|
|
Cyclin D1, D2 |
Inhibited |
|
|
Matrix metalloproteinase 1 |
Blocked (prevents collagen degradation) |
|
|
Matrix metalloproteinase 9 |
Decreased through gene interaction |
|
|
IκB kinase Rα |
Inhibited |
|
|
MAPK |
Blocked |
|
|
MAPKK |
Blocked |
|
|
Leukocyte migration |
Reduced (UV-B dependent) |
|
|
Tyrosinase |
Inhibited (reduces discoloration) |
|
|
Bcl-2 phosphorylation |
Inhibited |
|
|
Protein kinase B and C |
Reduced |
|
|
Hydroperoxidases |
Reduced |
|
|
GM-CSF |
Inhibited (wrinkle reduction) |
|
Antioxidant Mechanisms
|
Mechanism |
Action |
Source |
|
Free radical scavenging |
Neutralizes hydroxyl radicals, nitric oxide, superoxide anions |
|
|
Dual antioxidant effect |
Direct neutralization + boosts endogenous antioxidants |
|
|
Oxidative stress mitigation |
Activates Nrf2 pathway |
|
|
Lipid peroxidation reduction |
Decreases hydroperoxide |
|
|
Cell protection |
Protects against sodium nitroprusside-induced damage |
|
|
Caspase inhibition |
Full blockade of caspase 3 and 9 at 1-30 μmol |
|
Anti-Aging Pathways
|
Mechanism |
Action |
Source |
|
Collagen gene activation |
Activates estrogen receptor α and β (not γ) |
|
|
MMP inhibition |
Prevents collagen/elastin degradation |
|
|
SIRT-1 activation |
Mimics caloric restriction, improves cellular longevity |
|
|
AMPK-FOXO3 pathway |
Protects keratinocytes from H₂O₂ damage |
|
|
Autophagy promotion |
Eliminates abnormal cells via LC3-II increase |
|
UV Protection Mechanisms
|
Mechanism |
Action |
Source |
|
UV-B damage prevention |
Protects against photoaging |
|
|
Inflammatory cytokine reduction |
Reduces IL-6 and IL-8 (isobutyrate/butyrate forms) |
|
|
Skin edema reduction |
Decreases UV-induced swelling |
|
|
Erythema reduction |
Decreases UV-induced redness |
|
|
Wrinkle formation prevention |
Reduces UV-induced wrinkle number and length |
|
Melanogenesis Inhibition
|
Mechanism |
Action |
Source |
|
Tyrosinase inhibition |
Blocks melanin synthesis enzyme |
|
|
MITF blockade |
Inhibits microphthalmia-associated transcription factor |
|
|
Tyrosinase mRNA reduction |
Decreases enzyme expression |
|
|
DOPA chrome tautomerase inhibition |
Blocks melanin production pathway |
|
|
Melanin concentration decrease |
3-10 μmol dose reduces melanin in melanoma cells |
|
|
Melanosomal degradation |
Activates autophagy, lysosomal, proteasomal pathways |
|
Application Attributes
|
Application Type |
Concentration |
Purpose |
|
Anti-aging serums |
0.5-2% |
Wrinkles, fine lines, firmness |
|
Photoprotection products |
1-2% |
UV damage prevention |
|
Brightening treatments |
1% (resveratryl triglycolate 3-10 μmol) |
Hyperpigmentation, melanoma protection |
|
Antioxidant formulations |
0.5-1% |
Free radical defense |
|
Scar/wound healing |
1-2% topical |
Tissue regeneration |
|
Anti-inflammatory products |
0.5-1% |
Redness, irritation, dermatitis |
|
Oral supplements |
100-500 mg daily |
Systemic skin health |
Dosage Attributes
|
Parameter |
Value |
Source |
|
Topical Concentration |
0.5-2% in finished products |
General cosmetic use |
|
Melanogenesis Inhibition |
3-10 μmol resveratryl triglycolate |
|
|
UV Protection |
25-50 μmol (cell culture studies) |
|
|
Oral Supplementation |
100-500 mg daily |
|
|
Application Frequency |
1-2 times daily |
Standard skincare protocol |
|
Topical Results Timeline |
12 weeks for significant wrinkle/elasticity improvement |
|
|
Oral Results Timeline |
60 days for hydration/texture improvement |
|
How Resveratrol Works in YourHappyLife Formulations
Integration: YourHappyLife incorporates resveratrol as powerful antioxidant that neutralizes free radicals, protects against UV damage, brightens dullness, and supports firm, luminous, youthful-looking skin.
Multi-Pathway Action:
-
Antioxidant: Scavenges hydroxyl radicals, nitric oxide, superoxide anions → Prevents oxidative cellular damage
-
Collagen Protection: Inhibits MMP-1 and MMP-9 → Prevents collagen/elastin breakdown
-
Collagen Synthesis: Activates estrogen receptors α/β → Increases type A1 collagen gene expression
-
UV Defense: Blocks MAPK/MAPKK, reduces leukocyte migration → Prevents photoaging
-
Anti-Inflammatory: Reduces IL-6, IL-8 (isobutyrate/butyrate forms) → Calms skin, reduces redness
-
Brightening: Inhibits tyrosinase, MITF, melanin synthesis → Fades hyperpigmentation
-
Cellular Longevity: Activates SIRT-1, AMPK-FOXO3 → Protects cells, promotes autophagy
Derivative Comparison
|
Form |
IL-6/IL-8 Reduction |
Collagen A1 Increase |
TIMP-1 Increase |
Fibrillin 1 Effect |
MMP-9 Decrease |
|
Resveratrol isobutyrate |
Strongest |
High |
High |
Increases |
High |
|
Resveratrol butyrate |
Strongest |
High |
High |
Increases |
High |
|
Pure resveratrol |
Moderate |
Moderate |
Moderate |
No change |
Moderate |
Source:
Safety Attributes
|
Safety Parameter |
Status |
Source |
|
Clinical Validation |
Extensively studied in humans |
|
|
All Skin Types |
Suitable |
|
|
Sensitive Skin |
Well-tolerated |
|
|
Pregnancy Safety |
Consult healthcare provider |
General phytoestrogen caution |
|
Oral Safety |
GRAS at 100-500 mg/day |
|
|
Side Effects (topical) |
Minimal; rare mild irritation |
|
|
Side Effects (oral) |
None reported at standard doses |
|
|
Dermatological Conditions |
Benefits eczema, psoriasis, dermatitis |
|
|
Photosensitivity |
None (actually provides photoprotection) |
|
|
Long-term Use |
Safe for continuous application |
|
Formulation Challenges & Solutions
|
Challenge |
Issue |
Solution |
|
Low aqueous solubility |
Poor water dispersibility |
Use derivatives or nanocarriers |
|
Light sensitivity |
Degrades under UV exposure |
Opaque/amber packaging |
|
Oxidation susceptibility |
Loses potency with air exposure |
Airless pump, antioxidant stabilizers |
|
Bioavailability |
Limited skin penetration |
Nanoencapsulation, liposomes, derivatives |
Product Compatibility Attributes
|
Compatible Ingredient |
Synergy Effect |
|
Vitamin C |
Enhanced antioxidant protection |
|
Vitamin E |
Antioxidant network amplification |
|
Ferulic acid |
Photoprotection synergy |
|
Niacinamide |
Barrier + anti-inflammatory synergy |
|
Peptides |
Multi-pathway collagen stimulation |
|
Hyaluronic acid |
Hydration + antioxidant combination |
|
Bakuchiol |
Complementary retinol-like effects |